Disse data tyder på, at forekomsten af bekræftet rabdomyolyse for cerivastatin 0, 4 mg og 0, 8 mg i offentliggjorte undersøgelser er større end for andre statiner.
These data suggest that the incidence of confirmed rhabdomyolysis for cerivastatin 0.4mg and 0.8mg in published trials is greater than the other statins.